Marsh & McLennan Companies, Inc. MMC
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Alex Scott | Barclays | 203.84 $ | 221 $ | 17.16 % | 08/10/2025 |
| Bob Huang | Morgan Stanley | 203.2 $ | 215 $ | 11.80 % | 07/10/2025 |
| Bob Huang | Morgan Stanley | 207.735 $ | 220 $ | 12.27 % | 18/08/2025 |
| Ryan Tunis | Cantor Fitzgerald | 204.41 $ | 256 $ | 51.59 % | 12/08/2025 |
| Brian Meredith | UBS | 212.86 $ | 258 $ | 45.14 % | 21/07/2025 |
| Michael Zaremski | BMO Capital | 222.06 $ | 228 $ | 5.94 % | 22/10/2024 |
| Harry Fong | Roth Capital | 225.88 $ | 230 $ | 4.12 % | 18/10/2024 |
| Mark Dwelle | RBC Capital | 226.92 $ | 242 $ | 15.08 % | 18/10/2024 |
| Robert Cox | Goldman Sachs | 226.92 $ | 220 $ | -6.92 % | 18/10/2024 |
| Joshua Shanker | Bank of America Securities | 226.76 $ | 250 $ | 23.24 % | 10/10/2024 |
| Michael Zaremski | BMO Capital | 224.01 $ | 217 $ | -7.01 % | 01/10/2024 |
| Alex Scott | Barclays | 231.42 $ | 236 $ | 4.58 % | 04/09/2024 |
| Harry Fong | Roth Capital | 217.42 $ | 220 $ | 2.58 % | 19/07/2024 |
| Mark Dwelle | RBC Capital | 210.94 $ | 228 $ | 17.06 % | 28/06/2024 |
| Mark Dwelle | RBC Capital | 201.73 $ | 210 $ | 8.27 % | 19/04/2024 |
| Elyse Greenspan | Wells Fargo | 201.73 $ | 213 $ | 11.27 % | 19/04/2024 |
| David Motemaden | Evercore ISI | 201.73 $ | 221 $ | 19.27 % | 18/04/2024 |
| Paul Newsome | Piper Sandler | 196.29 $ | 211 $ | 14.71 % | 17/04/2024 |
| Andrew Kligerman | Credit Suisse | 165.7 $ | 157 $ | -8.70 % | 23/12/2022 |
| John Heagerty | Atlantic Equities | 163.01 $ | 185 $ | 21.99 % | 08/11/2022 |
| Paul Newsome | Piper Sandler | 132.19 $ | 145 $ | 12.81 % | 28/04/2021 |
| Phil Stefano | Deutsche Bank | 132.19 $ | 135 $ | 2.81 % | 28/04/2021 |